✦ LIBER ✦

Graft-versus-host disease: the need for a new terminology

✍ Scribed by Gerard M.J Bos; Gerard D Majoor; Peter J.C van Breda Vriesman

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 677 KB
Volume: 11
Category: Article
ISSN: 0167-5699
DOI: 10.1016/0167-5699(90)90170-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New strategies for preventing graft-vers

New strategies for preventing graft-versus-host disease

✍ William J Murphy; Bruce R Blazar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Graft-versus-host disease (GVHD) is a complex condition that can occur after allogeneic bone marrow transplantation and remains a significant cause of morbidity. GVHD occurs when donor immunocompetent T cells react to and attack the genetically disparate host. The etiology of GVHD is complex, with n

New therapeutic modalities in the treatm

New therapeutic modalities in the treatment of graft-versus-host disease

✍ N. Basara; M.G. Kiehl; A.A. Fauser 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 105 KB

The Department for Bone Marrow Transplantation and Hematology/Oncology was founded in 1994. Performing 90 transplantations per year it is one of the largest transplant centers in Germany, focusing on unrelated stem cell transplantations. Our extensive basic and clinical research programme is also co

Graft vs. host disease after liver trans

Graft vs. host disease after liver transplantation: A new approach is needed

✍ Roman Perri; Maha Assi; Jayant Talwalkar; Julie Heimbach; William Hogan; S. Brea 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Graft-vs.-host disease (GVHD) is a rare, serious complication of orthotopic liver transplantation (OLT). We have treated 5 patients to date with GVHD after OLT. A total of 78 patients worldwide have been reported to have experienced this complication. The means by which GVHD after OLT has been manag

High dose bolus methylprednisolone for t

High dose bolus methylprednisolone for the treatment of acute graft versus host disease

✍ Bacigalupo, Andrea ;Lint, Maria T. ;Frassoni, Francesco ;Podesta, Marina ;Venezi 📂 Article 📅 1983 🏛 Springer-Verlag ⚖ 508 KB

Nineteen patients with acute graft versus host disease (GvHD) following bone marrow transplantation (BMT) were treated with high dose bolus 6-methylprednisolone (BMPr), at the dose of 20 mg/kg/day i.v. for the first 3 days, 10 mg/kg/day i.v. for the following 4 days, and then at doses gradually tape

Regulatory T cells for the prevention of

Regulatory T cells for the prevention of graft-versus-host disease: Professionals defeat amateurs

✍ Matthias Edinger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

A multivariate approach for assessing se

A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation

✍ Rudolph S. Parrish; Linda J. Hazlett; Kerry D. Bridges; P. Jean Henslee-Downey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatme